Bicycle therapeutics to participate in upcoming investor conferences

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq: bcyc), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced that management will participate in the following investor conferences in march: td cowen 44th annual health care conference on wednesday, march 6, 2024; fireside chat at 11:10 a.m. et leerink partners global biopharma conference on monday, marc.
BCYC Ratings Summary
BCYC Quant Ranking